Interactions between the APOA5 -1131T>C and the FEN1 10154G>T polymorphisms on ω6 polyunsaturated fatty acids in serum phospholipids and coronary artery disease

Journal of Lipid Research

Volumn 51, Issue 11, 2010, Pages 3281-3288

  Park, Ju Yeon ^a   Paik, Jean Kyung ^a   Kim, Oh Yoen ^a   Chae, Jey Sook ^a   Jang, Yangsoo ^a,b,c   Lee, Jong Ho ^a  

^a Yonsei University   (South Korea)

^b Yonsei University   (South Korea)

^c Yonsei University College of Medicine   (South Korea)

Author keywords

Apolipoprotein A5; Arachidonic acid; CAD risk; Linoleic acid

Indexed keywords

APOLIPOPROTEIN A5; FLAP ENDONUCLEASE; FLAP ENDONUCLEASE 1; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LIPID PEROXIDE; LOW DENSITY LIPOPROTEIN CHOLESTEROL; OMEGA 6 FATTY ACID; PHOSPHOLIPID; TRIACYLGLYCEROL; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ADULT; ANTHROPOMETRY; ARTICLE; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; CORONARY ARTERY DISEASE; DISEASE ASSOCIATION; FATTY ACID ANALYSIS; FATTY ACID METABOLISM; FEMALE; GENE FREQUENCY; GENE INTERACTION; GENE MUTATION; GENETIC POLYMORPHISM; GENETIC VARIABILITY; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; PARTICLE SIZE; PHOSPHOLIPID BLOOD LEVEL; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM; TRIACYLGLYCEROL BLOOD LEVEL;

ADULT; AGED; AGED, 80 AND OVER; APOLIPOPROTEINS A; ARACHIDONIC ACIDS; CASE-CONTROL STUDIES; CORONARY ARTERY DISEASE; FATTY ACIDS, OMEGA-6; FEMALE; FLAP ENDONUCLEASES; HUMANS; LIPID PEROXIDES; LIPOPROTEINS, LDL; MALE; MIDDLE AGED; PARTICLE SIZE; PHOSPHOLIPIDS; POLYMORPHISM, SINGLE NUCLEOTIDE; TUMOR NECROSIS FACTOR-ALPHA;

EID: 78149311473     PISSN: 00222275     EISSN: 15397262     Source Type: Journal    
DOI: 10.1194/jlr.M010330     Document Type: Article

References (43)

1. van der Vliet, H. N., M. G. Sammels, A. C. Leegwater, J. H. Levels, P. H. Reitsma, W. Boers, and R. A. Chamuleau. 2001. Apolipoprotein A-V: a novel apolipoprotein associated with an early phase of liver regeneration. J. Biol. Chem. 276: 44512-44520.
2. Merkel, M., B. Loeffler, M. Kluger, N. Fabig, G. Geppert, L. A. Pennacchio, A. Laatsch, and J. Heeren. 2005. Apolipoprotein AV accelerates plasma hydrolysis of triglyceride-rich lipoproteins by interaction with proteoglycan-bound lipoprotein lipase. J. Biol. Chem. 280: 21553-21560.
3. Schaap, F. G., P. C. Rensen, P. J. Voshol, C. Vrins, H. N. van der Vliet, R. A. Chamuleau, L. M. Havekes, A. K. Groen, and K. W. van Dijk. 2004. ApoAV reduces plasma triglycerides by inhibiting very low density lipoprotein- triglyceride (VLDL-TG) production and stimulating lipoprotein lipase-mediated VLDL-TG hydrolysis. J. Biol. Chem. 279: 27941-27947.
4. Pennacchio, L. A., and E. M. Rubin. 2003. Apolipoprotein A5, a newly identified gene that affects plasma triglyceride levels in humans and mice. Arterioscler. Thromb. Vasc. 23: 529-534.
5. Jang, Y., J. K. Paik, Y. J. Hyun, J. S. Chae, J. Y. Kim, J. R. Choi, S. H. Lee, D. J. Shin, J. M. Ordovas, and J. H. Lee. 2009. The apolipoprotein A5-1131T>C promoter polymorphism in Koreans: association with plasma APOA5 and serum triglyceride concentrations, LDL particle size and coronary artery disease. Clin. Chim. Acta. 402: 83-87.
6. Lai, C. Q., D. Corella, S. Demissie, L. A. Cupples, X. Adiconis, Y. Zhu, L. D. Parnell, K. L. Tucker, and J. M. Ordovas. 2006. Dietary intake of n-6 fatty acids modulates effect of apolipoprotein A5 gene on plasma fasting triglycerides, remnant lipoprotein concentrations, and lipoprotein particle size: the Framingham Heart Study. Circulation. 113: 2062-2070.
7. Corella, D., C. Q. Lai, S. Demissie, L. A. Cupples, A. K. Manning, K. L. Tucker, and J. M. Ordovas. 2007. APOA5 gene variation modulates the effects of dietary fat intake on body mass index and obesity risk in the Framingham Heart Study. J. Mol. Med. 85: 119-128.
8. Plakké, T., J. Berkel, A. C. Beynen, R. J. Hermus, and M. B. Katan. 1983. Relationship between the fatty acid composition of the diet and that of the subcutaneous adipose tissue in individual human subjects. Hum. Nutr. Appl. Nutr. 37: 365-372.
9. Dougherty, R. M., C. Galli, A. Ferro-Luzzi, and J. M. Iacono. 1987. Lipid and phospholipid fatty acid composition of plasma, red blood cells, and platelets and how they are affected by dietary lipids: a study of normal subjects from Italy, Finland, and the USA. Am. J. Clin. Nutr. 45: 443-455.
10. Vessby, B. 2003. Dietary fat, fatty acid composition in plasma and the metabolic syndrome. Curr. Opin. Lipidol. 14: 15-19.
11. Vessby, B., M. Uusitupa, K. Hermansen, G. Riccardi, A. A. Rivellese, L. C. Tapsell, C. Nälsén, L. Berglund, A. Louheranta, B. M. Rasmussen, et al. 2001. Substituting dietary saturated for monoun-saturated fat impairs insulin sensitivity in healthy men and women: the KANWU Study. Diabetologia. 44: 312-319.
12. Marquardt, A., H. Stöhr, K. White, and B. H. Weber. 2000. cDNA cloning, genomic structure, and chromosomal localization of three members of the human fatty acid desaturase family. Genomics. 66: 175-183.
13. Cho, H. P., M. T. Nakamura, and S. D. Clarke. 1999. Cloning, expression, and nutritional regulation of the mammalian delta-6 desaturase. J. Biol. Chem. 274: 471-477.
14. Cho, H. P., M. Nakamura, and S. D. Clarke. 1999. Cloning, expression, and fatty acid regulation of the human delta-5 desaturase. J. Biol. Chem. 274: 37335-37339.
15. Tanaka, T., J. Shen, G. R. Abecasis, A. Kisialiou, J. M. Ordovas, J. M. Guralnik, A. Singleton, S. Bandinelli, A. Cherubini, D. Arnett, et al. 2009. Genome-wide association study of plasma poly-unsaturated fatty acids in the InCHIANTI Study. PLoS Genet. 5: e1000338.
16. Obukowicz, M. G., A. Raz, P. D. Pyla, J. G. Rico, J. M. Wendling, and P. Needleman. 1998. Identification and characterization of a novel delta6/delta5 fatty acid desaturase inhibitor as a potential anti-inflammatory agent. Biochem. Pharmacol. 55: 1045-1058.
17. Malerba, G., L. Schaeffer, L. Xumerle, N. Klopp, E. Trabetti, M. Biscuola, U. Cavallari, R. Galavotti, N. Martinelli, P. Guarini, et al. 2008. SNPs of the FADS gene cluster are associated with polyunsaturated fatty acids in cohort of patients with cardiovascular disease. Lipids. 43: 289-299.
18. Funk, C. D. 2001. Prostaglandins and leukotrienes: advances in eicosanoid biology. Science. 294: 1871-1875.
19. Brash, A. R. 2001. Arachidonic acid as a bioactive molecule. J. Clin. Invest. 107: 1339-1345.
20. Folch, J., M. Lees, and G. H. Sloane Stanley. 1957. A simple method for the isolation and purification of total lipids from animal tissues. J. Biol. Chem. 226: 497-509.
21. Lepage, G., and C. C. Roy. 1986. Direct transesterification of all classes of lipids in a one-step reaction. J. Lipid Res. 27: 114-120.
22. Rensen, P. C., K. W. van Dijk, and L. M. Havekes. 2005. Apolipoprotein AV: low concentration, high impact. Arterioscler. Thromb. Vasc. 25: 2445-2447.
23. Weinberg, R. B., V. R. Cook, J. A. Beckstead, D. D. Martin, J. W. Gallagher, G. S. Shelness, and R. O. Ryan. 2003. Structure and interfacial properties of human apolipoprotein A-V. J. Biol. Chem. 278: 34438-34444.
24. Grosskopf, I., N. Baroukh, S. J. Lee, Y. Kamari, D. Harats, E. M. Rubin, L. A. Pennacchio, and A. D. Cooper. 2005. APOA5 deficiency results in marked hypertriglyceridemia attributable to decreased lipolysis of triglyceride-rich lipoproteins and removal of their remnants. Arterioscler. Thromb. Vasc. 25: 2573-2579.
25. Marcais, C., B. Verges, S. Charriere, V. Pruneta, M. Merlin, S. Billon, L. Perrot, J. Drai, A. Sassolas, L. A. Pennacchio, et al. 2005. Apoa5 Q139X truncation predisposes to late-onset hyperchylomicronemia due to lipoprotein lipase impairment. J. Clin. Invest. 115: 2862-2869.
26. Jang, Y., J. Y. Kim, O. Y. Kim, J. E. Lee, H. Cho, J. M. Ordovas, and J. H. Lee. 2004. The -1131T->C polymorphism in the apolipoprotein A5 gene is associated with postprandial hypertriacylglycerolemia; elevated small, dense LDL concentrations; and oxidative stress in nonobese Korean men. Am. J. Clin. Nutr. 80: 832-840.
27. Emken, E. A., R. O. Adlof, and R. M. Gulley. 1994. Dietary linoleic acid influences desaturation and acylation of deuterium-labeled linoleic and linolenic acids in young adult males. Biochim. Biophys. Acta. 1213: 277-288.
28. Di Stasi, D., R. Bernasconi, R. Marchiali, R. M. Marfisi, G. Rossi, G. Rognoni, and M. T. Sacconi. 2004. Early modifications of fatty acid composition in plasma phospholipids, platelets and mononucleates of healthy volunteers after low doses of n-3 polyunsaturated fatty acids. Eur. J. Clin. Pharmacol. 60: 183-190.
29. Schaeffer, L., H. Gohlke, M. Müller, I. M. Heid, L. J. Palmer, I. Kompauer, H. Demmelmair, T. Illig, B. Koletzko, and J. Heinrich. 2006. Common genetic variants of the FADS1 FADS2 gene cluster and their reconstructed haplotypes are associated with the fatty acid composition in phospholipids. Hum. Mol. Genet. 15: 1745-1756.
30. Martinelli, N., D. Girelli, G. Malerba, P. Guarini, T. Illig, E. Trabetti, M. Sandri, S. Friso, F. Pizzolo, L. Schaeffer, et al. 2008. FADS genotypes and desaturase activity estimated by the ratio of arachidonic acid to linoleic acid are associated with inflammation and coronary artery disease. Am. J. Clin. Nutr. 88: 941-949.
31. Das, U. N. 2007. A defect in the activity of Delta6 and Delta5 desaturases may be a factor in the initiation and progression of atherosclerosis. Prostaglandins Leukot. Essent. Fatty Acids. 76: 251-268.
32. Glew, R. H., H. Okolie, Y. S. Huang, L. T. Chuang, O. Suberu, M. Crossey, and D. J. VanderJagt. 2004. Abnormalities in the fatty-acid composition of the serum phospholipids of stroke patients. J. Natl. Med. Assoc. 96: 826-832.
33. Warensjo, E., U. Riserus, and B. Vessby. 2005. Fatty acid composition of serum lipids predicts the development of the metabolic syndrome in men. Diabetologia. 48: 1999-2005. (Pubitemid 41416909)
34. Warensjo, E., M. Ohrvall, and B. Vessby. 2006. Fatty acid composition and estimated desaturase activities are associated with obesity and lifestyle variables in men and women. Nutr. Metab. Cardiovasc. Dis. 16: 128-136.
35. Warensjo, E., J. Sundstrom, L. Lind, and B. Vessby. 2006. Factor analysis of fatty acids in serum lipids as a measure of dietary fat quality in relation to the metabolic syndrome in men. Am. J. Clin. Nutr. 84: 442-448.
36. Kark, J. D., N. A. Kaufmann, F. Binka, N. Goldberger, and E. M. Berry. 2003. Adipose tissue n-6 fatty acids and acute myocardial infarction in a population consuming a diet high in polyunsaturated fatty acids. Am. J. Clin. Nutr. 77: 796-802.
37. Baylin, A., and H. Campos. 2004. Arachidonic acid in adipose tissue is associated with nonfatal acute myocardial infarction in the central valley of Costa Rica. J. Nutr. 134: 3095-3099. (Pubitemid 39470090)
38. Stafforini, D. M., J. R. Sheller, T. S. Blackwell, A. Sapirstein, F. E. Yull, T. M. McIntyre, J. V. Bonventre, S. M. Prescott, and L. J. Roberts. 2006. Release of free F2-isoprostanes from esterified phospholipids is catalyzed by intracellular and plasma platelet-activating factor acetylhydrolases. J. Biol. Chem. 281: 4616-4623.
39. Voss, P., and W. Siems. 2006. Clinical oxidation parameters of aging. Free Radic. Res. 40: 1339-1349.
40. Schwedhelm, E., A. Bartling, H. Lenzen, D. Tsikas, R. Maas, J. Brümmer, F. M. Gutzki, J. Berger, J. C. Frölich, and R. H. Böger. 2004. Urinary 8-iso-prostaglandin F2alpha as a risk marker in patients with coronary heart disease: a matched case-control study. Circulation. 109: 843-848.
41. Wolfram, R., A. Oguogho, B. Palumbo, and H. Sinzinger. 2005. Enhanced oxidative stress in coronary heart disease and chronic heart failure as indicated by an increased 8-epi-PGF(2alpha). Eur. J. Heart Fail. 7: 167-172.
42. Vassalle, C., L. Petrozzi, N. Botto, M. G. Andreassi, and G. C. Zucchelli. 2004. Oxidative stress and its association with coronary artery disease and different atherogenic risk factors. J. Intern. Med. 256: 308-315.
43. Huang, H., W. Mai, D. Liu, Y. Hao, J. Tao, and Y. Dong. 2008. The oxidation ratio of LDL: a predictor for coronary artery disease. Dis. Markers. 24: 341-349.